OHSU

IRB #

IRB00008634

Title

First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial

Principal Investigator

Eric Suhler

Study Purpose

to evaluate methotrexate and mycophenolate mofetil in treating uveitis

Medical Condition(s)

non-infectious uveitis

Eligibility Criteria

must have active uveitis

Age Range

16 - 100

Healthy Volunteers Needed

No

Duration of Participation

up to 1 year

Minors Included

No

Contact

Tracy Giles 503-494-0482, gilest@ohsu.edu

Sponsor

University of California, San Francisco

Recruitment End

05/30/2014

Compensation Provided

No


Go Back